A window into a public programme for prevention of mother-to-child transmission of hiv: Evidence from a prospective clinical trial

Southern African Journal of HIV Medicine

Volumn , Issue 36, 2009, Pages 16-19

  Cotton, M ^a   Kim, S ^b   Rabie, H ^a   Coetzee, J ^a   Nachman, S ^c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; NEVIRAPINE; VIRUS DNA; ZIDOVUDINE;

ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; INTRAPARTUM CARE; LABOR; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; POSTNATAL CARE; PREGNANCY; PRENATAL CARE; PROSPECTIVE STUDY; SCREENING; SINGLE DRUG DOSE; SOUTH AFRICA; VERTICAL TRANSMISSION;

EID: 75749089633     PISSN: 16089693     EISSN: None     Source Type: Journal    
DOI: 10.4102/sajhivmed.v10i4.257     Document Type: Article

References (13)

1. National Department of Health. National HIV and Syphilis Seroprevolence Survey South Africa 2005. Pretoria: National Department of Health, 2005.
2. Abdullah MF, Young T, Bitalo L, Coetzee N, Myers JE. Public health lessons from a pilot programme to reduce mother-to-child transmission of HIV-1 in Khayalitsha. S Afr Med J 2001; 81: 579-583.
3. Quay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354: 795-802.
4. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351(3): 217-228.
5. Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 2008; 12(2): 225-227.
6. Bobat R, Coovadia H, Coutsoudis A, Moodley D. Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa. Pediatr Infect Dis J 1996; 15(7): 604-610.
7. The PETRA study team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002; 359: 1178-1186.
8. Good Start Study Team. The Good Start Study: Early Perinatal Transmission, Infant Feeding and HIV-Free Survival. Paper presented at the 25th Conference on Priorities in Perinatal Care, 7 - 10 March 2006, Drakensberg, KwaZulu-Natal.
9. World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HN Infection in Infants in Resource-limited Settings: Towords Universal Access. Recommendations for a Public Health Approach. Geneva: WHO, 2006.
10. Delva W, Draper B, Temmerman M. Implementation of single-dose nevirapine for prevention of MTCT of HIV - lessons from Cape Town. S Afr Med J 2006; 96: 706-709.
11. Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000; 343(14): 982-991.
12. Wade NA, Birkhead GS. Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998; 339(20): 1409-1414.
13. Gray GE, Urban M, Chersich MF, et al. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS 2005; 19(12): 1289-1297.